Access Viewpoint here:

Nonclinical evidence for drug effectiveness can support streamlined antibacterial drug development – by Tina Guina and Edward A. Weinstein

Authors:

Tina Guina, Edward A. Weinstein

Tags:
Antimicrobial Viewpoint article, Viewpoint, PK/PD, HAP/VAP, Tuberculosis, Acinetobacter baumannii, XDR